Education
About Us
Working with TipRanks
Follow Us
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
RESEARCH TOOLSreports
Total Valuation
Simcere Pharmaceutical Group Limited has a market cap or net worth of HK$31.03B. The enterprise value is ―.
Market CapHK$31.03B
Enterprise Value―
Share Statistics
Simcere Pharmaceutical Group Limited has 2,486,320,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,486,320,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Simcere Pharmaceutical Group Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.00M
Profits Per Employee112.40K
Employee Count6,584
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Simcere Pharmaceutical Group Limited is ―. Simcere Pharmaceutical Group Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Simcere Pharmaceutical Group Limited had revenue of 6.61B and earned 714.76M in profits. Earnings per share was 0.27.
Revenue6.61B
Gross Profit4.98B
Operating Income711.80M
Pretax Income740.04M
Net Income714.76M
EBITDA1.08B
Earnings Per Share (EPS)0.27
Cash Flow
In the last 12 months, operating cash flow was 1.10B and capital expenditures -483.18M, giving a free cash flow of 612.56M billion.
Operating Cash Flow1.10B
Free Cash Flow612.56M
Free Cash Flow per Share0.25
Dividends & Yields
Simcere Pharmaceutical Group Limited pays an annual dividend of HK$0.171, resulting in a dividend yield of 1.41%
Dividend Per ShareHK$0.171
Dividend Yield1.41%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change125.17%
50-Day Moving Average9.27
200-Day Moving Average7.43
Relative Strength Index (RSI)73.97
Average Volume (3m)13.25M
Important Dates
Simcere Pharmaceutical Group Limited upcoming earnings date is Mar 31, 2023, TBA Not Confirmed.
Last Earnings DateAug 31, 2022
Next Earnings DateMar 31, 2023
Ex-Dividend DateJun 18, 2025
Financial Position
Simcere Pharmaceutical Group Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Simcere Pharmaceutical Group Limited has paid 26.09M in taxes.
Income Tax26.09M
Effective Tax Rate―
Enterprise Valuation
Simcere Pharmaceutical Group Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Simcere Pharmaceutical Group Limited has HK$3.06B in cash and marketable securities with ¥1.18B in debt, giving a net cash position of -HK$1.87B billion.
Cash & Marketable SecuritiesHK$3.06B
Total Debt¥1.18B
Net Cash-HK$1.87B
Net Cash Per Share-HK$0.75
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Simcere Pharmaceutical Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―